EA201900117A1 - Комбинированная вакцина и способ её производства (варианты) - Google Patents
Комбинированная вакцина и способ её производства (варианты)Info
- Publication number
- EA201900117A1 EA201900117A1 EA201900117A EA201900117A EA201900117A1 EA 201900117 A1 EA201900117 A1 EA 201900117A1 EA 201900117 A EA201900117 A EA 201900117A EA 201900117 A EA201900117 A EA 201900117A EA 201900117 A1 EA201900117 A1 EA 201900117A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- antigens
- antigen
- ipv
- rotavirus
- prf
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/295—Polyvalent viral antigens; Mixtures of viral and bacterial antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/15—Reoviridae, e.g. calf diarrhea virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/099—Bordetella
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/125—Picornaviridae, e.g. calicivirus
- A61K39/13—Poliovirus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55544—Bacterial toxins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/12011—Reoviridae
- C12N2720/12311—Rotavirus, e.g. rotavirus A
- C12N2720/12334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32611—Poliovirus
- C12N2770/32634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN201621029037 | 2016-08-26 | ||
| PCT/IB2017/055100 WO2018037365A1 (en) | 2016-08-26 | 2017-08-24 | Multivalent vaccine composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EA201900117A1 true EA201900117A1 (ru) | 2019-09-30 |
Family
ID=60083359
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EA201900117A EA201900117A1 (ru) | 2016-08-26 | 2017-08-24 | Комбинированная вакцина и способ её производства (варианты) |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US11235054B2 (https=) |
| EP (1) | EP3503917B1 (https=) |
| JP (3) | JP7384667B2 (https=) |
| KR (1) | KR102607295B1 (https=) |
| CN (1) | CN110691611A (https=) |
| AU (1) | AU2017316768B2 (https=) |
| CA (1) | CA3032901A1 (https=) |
| CU (1) | CU24682B1 (https=) |
| EA (1) | EA201900117A1 (https=) |
| IL (1) | IL264605B2 (https=) |
| MX (1) | MX2019001780A (https=) |
| MY (1) | MY191163A (https=) |
| PE (1) | PE20200004A1 (https=) |
| PH (1) | PH12019500404B1 (https=) |
| SG (1) | SG11201900365WA (https=) |
| UA (1) | UA129115C2 (https=) |
| WO (1) | WO2018037365A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG11201900365WA (en) * | 2016-08-26 | 2019-02-27 | Serum Institute Of India Pvt Ltd | Multivalent vaccine composition |
| US11793873B2 (en) | 2017-05-10 | 2023-10-24 | University Of Massachusetts | Bivalent dengue/hepatitis B vaccines |
| MX2021004233A (es) * | 2018-10-12 | 2021-08-16 | Serum Inst Of India Private Ltd | Composicion de vacuna combinada que comprende dosis reducidas del virus inactivado de la polio y metodo de preparacion de la misma. |
| JOP20200214A1 (ar) | 2019-09-03 | 2021-03-03 | Serum Institute Of India Pvt Ltd | تركيبات مولدة للمناعة ضد الأمراض المعوية وطرق لتحضيرها |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2008536515A (ja) | 2005-04-18 | 2008-09-11 | ノバルティス ヴァクシンズ アンド ダイアグノスティクス， インコーポレイテッド | ワクチンの調製のためのｂ型肝炎ウイルス表面抗原の発現 |
| US8945582B2 (en) * | 2006-09-07 | 2015-02-03 | Glaxosmithkline Biologicals S.A. | Vaccine |
| PE20100365A1 (es) * | 2008-10-24 | 2010-05-21 | Panacea Biotec Ltd | Novedosas vacunas de combinacion con tos ferina de celulas enteras y metodo para su elaboracion |
| CA2763359C (en) | 2009-05-12 | 2021-07-27 | Baoming Jiang | New human rotavirus strains and vaccines |
| EP3459562B1 (en) * | 2011-01-05 | 2024-03-20 | Bharat Biotech International Limited | A combination heptavalent vaccine |
| WO2012117377A1 (en) * | 2011-03-02 | 2012-09-07 | Novartis Ag | Combination vaccines with lower doses of antigen and/or adjuvant |
| SI3204494T1 (sl) * | 2014-10-07 | 2020-08-31 | Serum Institute Of India Private Limited | Izboljšane metode za neaktivacijo poliovirusa, adjuvans adsorpcije |
| SG11201900365WA (en) * | 2016-08-26 | 2019-02-27 | Serum Institute Of India Pvt Ltd | Multivalent vaccine composition |
-
2017
- 2017-08-24 SG SG11201900365WA patent/SG11201900365WA/en unknown
- 2017-08-24 PE PE2019000409A patent/PE20200004A1/es unknown
- 2017-08-24 US US16/327,513 patent/US11235054B2/en active Active
- 2017-08-24 KR KR1020197008377A patent/KR102607295B1/ko active Active
- 2017-08-24 CU CU2019000013A patent/CU24682B1/es unknown
- 2017-08-24 UA UAA201902890A patent/UA129115C2/uk unknown
- 2017-08-24 CN CN201780052380.5A patent/CN110691611A/zh active Pending
- 2017-08-24 PH PH1/2019/500404A patent/PH12019500404B1/en unknown
- 2017-08-24 CA CA3032901A patent/CA3032901A1/en active Pending
- 2017-08-24 EA EA201900117A patent/EA201900117A1/ru unknown
- 2017-08-24 WO PCT/IB2017/055100 patent/WO2018037365A1/en not_active Ceased
- 2017-08-24 MY MYPI2019001011A patent/MY191163A/en unknown
- 2017-08-24 MX MX2019001780A patent/MX2019001780A/es unknown
- 2017-08-24 EP EP17783992.5A patent/EP3503917B1/en active Active
- 2017-08-24 JP JP2019532214A patent/JP7384667B2/ja active Active
- 2017-08-24 IL IL264605A patent/IL264605B2/en unknown
- 2017-08-24 AU AU2017316768A patent/AU2017316768B2/en active Active
-
2021
- 2021-07-16 JP JP2021118038A patent/JP2021181445A/ja active Pending
-
2023
- 2023-10-06 JP JP2023174503A patent/JP2024009899A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| MX2019001780A (es) | 2020-01-13 |
| PH12019500404A1 (en) | 2020-01-20 |
| PH12019500404B1 (en) | 2024-05-15 |
| AU2017316768B2 (en) | 2024-04-11 |
| JP2021181445A (ja) | 2021-11-25 |
| BR112019003419A2 (pt) | 2019-05-21 |
| AU2017316768A1 (en) | 2019-04-11 |
| NZ751127A (en) | 2025-08-29 |
| EP3503917B1 (en) | 2024-07-03 |
| IL264605B2 (en) | 2023-04-01 |
| US11235054B2 (en) | 2022-02-01 |
| US20190175722A1 (en) | 2019-06-13 |
| WO2018037365A1 (en) | 2018-03-01 |
| CU20190013A7 (es) | 2019-10-04 |
| JP2024009899A (ja) | 2024-01-23 |
| KR20190142311A (ko) | 2019-12-26 |
| SG11201900365WA (en) | 2019-02-27 |
| UA129115C2 (uk) | 2025-01-22 |
| IL264605B (en) | 2022-12-01 |
| IL264605A (en) | 2019-02-28 |
| CU24682B1 (es) | 2023-10-06 |
| EP3503917A1 (en) | 2019-07-03 |
| MY191163A (en) | 2022-06-03 |
| PE20200004A1 (es) | 2020-01-06 |
| JP2019526635A (ja) | 2019-09-19 |
| JP7384667B2 (ja) | 2023-11-21 |
| CN110691611A (zh) | 2020-01-14 |
| WO2018037365A8 (en) | 2018-09-20 |
| CA3032901A1 (en) | 2018-03-01 |
| KR102607295B1 (ko) | 2023-11-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JOP20180069B1 (ar) | تركيبة مولدة للمناعة لها ثبات محسن، توليد مناعي معزز وتوليد قدرة تفاعلية منخفض، وعملية لتحضيرها | |
| EA201900117A1 (ru) | Комбинированная вакцина и способ её производства (варианты) | |
| EP0833662B1 (en) | A vaccine composition comprising a polysaccharide conjugate antigen adsorbed onto aluminium phosphate | |
| RU2013136397A (ru) | Комбинированная семивалентная вакцина | |
| MA32819B1 (fr) | Vaccin combine notamment contre la coqueluche acellulaire | |
| RU2016110576A (ru) | Бактериальная вакцина и способы ее получения | |
| JP2022502469A (ja) | 低減用量の不活化ポリオウイルスを含む混合ワクチン組成物およびそれを調製するための方法 | |
| JP2012506420A (ja) | 全細胞百日咳を含む混合ワクチン | |
| RU2015111987A (ru) | Несшитые бесклеточные коклюшные антигены для применения в комбинированных вакцинах | |
| AR118407A1 (es) | Composición de vacuna multivalente | |
| AR101256A1 (es) | Composición vacunal que comprende ipv y ciclodextrinas | |
| RU2014147491A (ru) | Антигены и антигенные композиции | |
| MY208608A (en) | Liquid sextuple vaccine composition | |
| NZ751127B2 (en) | Multivalent vaccine composition | |
| CN1215337A (zh) | 包含一种多糖抗原－载体蛋白共轭物和游离载体蛋白的疫苗 | |
| OA21991A (en) | Improved methods for enterovirus inactivation, adjuvant adsorption and dose reduced vaccine compositions obtained thereof. | |
| JP2000511553A (ja) | ボルデテラ・ペルツッシスの外膜タンパク質フラグメントを有してなるワクチン組成物 | |
| TH67338B (th) | การคงตัวของโปรตีนในสารแขวนตะกอนที่เป็นน้ำ (aqueous suspenion) | |
| HK1009764B (en) | A vaccine composition comprising a polysaccharide conjugate antigen adsorbed onto aluminium phosphate | |
| TH104386A (th) | การคงตัวของโปรตีนในสารแขวนตะกอนที่เป็นน้ำ (aqueous suspenion) |